Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial

BACKGROUND: Currently no effective antiviral therapy has been found to treat COVID-19. The aim of this trial was to assess if the addition of sofosbuvir and daclatasvir improved clinical outcomes in patients with moderate or severe COVID-19. METHODS: This was an open-label, multicentre, randomized c...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Antimicrob Chemother
Hoofdauteurs: Sadeghi, Anahita, Ali Asgari, Ali, Norouzi, Alireza, Kheiri, Zahedin, Anushirvani, Amir, Montazeri, Mahnaz, Hosamirudsai, Hadiseh, Afhami, Shirin, Akbarpour, Elham, Aliannejad, Rasoul, Radmard, Amir Reza, Davarpanah, Amir H, Levi, Jacob, Wentzel, Hannah, Qavi, Ambar, Garratt, Anna, Simmons, Bryony, Hill, Andrew, Merat, Shahin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2020
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7454592/
https://ncbi.nlm.nih.gov/pubmed/32812039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa334
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items